Unknown

Dataset Information

Multicentre, open-label, randomised, controlled trial to compare early intervention with calcimimetics and conventional therapy in preventing coronary artery calcification in patients with secondary hyperparathyroidism (UPCOMING): a study protocol.


ABSTRACT:

Introduction

Coronary artery and heart valve calcification is a risk factor for cardiovascular death in haemodialysis patients, so calcification prevention should be started as early as possible. Treatment with concomitant calcimimetics and low-dose vitamin D receptor activators (VDRAs) is available, but not enough evidence has been obtained on the efficacy of this regimen, particularly in patients with short dialysis duration. Therefore, this study will evaluate the efficacy and safety of early intervention with upacicalcet, a calcimimetic used to prevent coronary artery calcification in this patient population.

Methods and analysis

This multicentre, open-label, randomised, parallel-group controlled study will compare an early intervention group, which received upacicalcet

SUBMITTER: Inaguma D 

PROVIDER: S-EPMC10823999 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature